Publication | Closed Access

Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan®) and α-adrenergic blocking drugs

Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineα-Adrenergic Blocking DrugsNatural SciencesMechanism Of ActionExperimental PharmacologyPharmacotherapy-2-Imidazoline HydrochloridePharmacologyPharmaceutical ChemistrySt 155Drug DiscoveryAlpha-adrenergic Pharmacology